ESR1 and breast carcinoma: PgR expression was considered to be related to the response to tamoxifen, and several retrospective studies including our previous study indicated that PgR expression according to the Allred score was a significant prognostic factor in ER-positive, HER2-negative breast cancer in patients treated with tamoxifen [8, 19].